We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

188 hedge funds and large institutions have $3.52B invested in Medicines Co in 2018 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 69 increasing their positions, 62 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

137% more call options, than puts

Call options by funds: $79.6M | Put options by funds: $33.6M

11% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 62

10% more capital invested

Capital invested by funds: $3.2B → $3.52B (+$321M)

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

0% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 21

1% less funds holding

Funds holding: 190188 (-2)

Holders
188
Holders Change
-2
Holders Change %
-1.05%
% of All Funds
4.3%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.18%
New
21
Increased
69
Reduced
62
Closed
21
Calls
$79.6M
Puts
$33.6M
Net Calls
+$46.1M
Net Calls Change
+$26.1M
Name Holding Trade Value Shares
Change
Change in
Stake
CIM
126
CIM Investment Management
Pennsylvania
$541K
Public Employees Retirement Association of Colorado
127
Public Employees Retirement Association of Colorado
Colorado
$520K
COPPSERS
128
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$503K +$445K +13,702 New
Two Sigma Advisers
129
Two Sigma Advisers
New York
$499K +$442K +13,600 New
PNC Financial Services Group
130
PNC Financial Services Group
Pennsylvania
$481K +$82.9K +2,550 +24%
SG Americas Securities
131
SG Americas Securities
New York
$457K +$239K +7,362 +144%
Russell Investments Group
132
Russell Investments Group
United Kingdom
$453K -$162 -5 -0%
FIM
133
Freedom Investment Management
Connecticut
$449K +$397K +12,230 New
OTPPB
134
Ontario Teachers' Pension Plan Board
Ontario, Canada
$443K +$392K +12,062 New
XK
135
Xact Kapitalforvaltning
Sweden
$421K +$39K +1,200 +12%
AB
136
Amalgamated Bank
New York
$407K +$36.9K +1,136 +11%
CGH
137
Crossmark Global Holdings
Texas
$399K
ACM
138
Atika Capital Management
New York
$396K +$351K +10,813 New
FCM
139
Flinton Capital Management
Pennsylvania
$365K +$14.4K +442 +5%
RCM
140
Riverhead Capital Management
Delaware
$341K
Two Sigma Investments
141
Two Sigma Investments
New York
$341K +$302K +9,282 New
Verition Fund Management
142
Verition Fund Management
Connecticut
$322K +$285K +8,778 New
TAM
143
Tyers Asset Management
Texas
$301K +$11.8K +364 +5%
RJA
144
Raymond James & Associates
Florida
$287K
Nisa Investment Advisors
145
Nisa Investment Advisors
Missouri
$286K -$97.5K -3,000 -28%
VF
146
Virtu Financial
New York
$286K +$253K +7,797 New
OWIM
147
Old West Investment Management
California
$281K +$18.2K +560 +8%
OPPM
148
Opus Point Partners Management
New York
$257K
SCM
149
Shelton Capital Management
Colorado
$239K
NA
150
Neuburgh Advisers
California
$236K +$9.29K +286 +5%

MDCO Hedge Fund Activity: Q2 2018 in Review

188 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q2 2018, worth a combined $3.52B — up 10% from $3.2B a quarter earlier.

Fund positioning in MDCO was balanced in Q2 2018: 21 funds opened new positions, 21 closed out, 69 added to existing stakes and 62 trimmed.

The largest buyer was BlackRock, adding an estimated $17.5M. The largest seller was Franklin Resources, cutting an estimated $39.4M.

  • 188 institutional investors held Medicines Co (MDCO) as of Q2 2018, down from 190 in Q1 2018.
  • Funds reported $3.52B of Medicines Co stock for Q2 2018, up 10% quarter-over-quarter.
  • 21 funds opened new Medicines Co positions in Q2 2018 and 21 closed out, a net change of 0 holders.
  • The largest Medicines Co buyer in Q2 2018 was BlackRock, an estimated $17.5M added.
  • The largest Medicines Co seller in Q2 2018 was Franklin Resources, an estimated $39.4M sold.

Based on aggregated 13F filings for Q2 2018.